ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 117 filers reported holding ARENA PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 0.09 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $28,000 | +3.7% | 19,241 | 0.0% | 0.00% | – |
| Q4 2016 | $27,000 | -60.3% | 19,241 | -50.0% | 0.00% | – |
| Q3 2016 | $68,000 | +112.5% | 38,482 | +100.0% | 0.00% | – |
| Q2 2016 | $32,000 | -15.8% | 19,241 | 0.0% | 0.00% | – |
| Q1 2016 | $38,000 | +2.7% | 19,241 | 0.0% | 0.00% | – |
| Q4 2015 | $37,000 | 0.0% | 19,241 | 0.0% | 0.00% | – |
| Q3 2015 | $37,000 | -58.4% | 19,241 | 0.0% | 0.00% | – |
| Q2 2015 | $89,000 | +6.0% | 19,241 | 0.0% | 0.00% | – |
| Q1 2015 | $84,000 | +27.3% | 19,241 | 0.0% | 0.00% | – |
| Q4 2014 | $66,000 | -19.5% | 19,241 | -1.2% | 0.00% | – |
| Q3 2014 | $82,000 | -27.4% | 19,472 | 0.0% | 0.00% | – |
| Q2 2014 | $113,000 | +73.8% | 19,472 | +90.0% | 0.00% | – |
| Q1 2014 | $65,000 | +32.7% | 10,246 | +24.3% | 0.00% | – |
| Q4 2013 | $49,000 | – | 8,246 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MANGROVE PARTNERS IM, LLC | 867,700 | $3,636,000 | 1.05% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,847,999 | $24,503,000 | 0.89% |
| MANGROVE PARTNERS IM, LLC | 210,900 | $884,000 | 0.26% |
| Lyons Wealth Management, LLC. | 56,775 | $238,000 | 0.25% |
| Callan Capital, LLC | 76,118 | $319,000 | 0.09% |
| SABBY MANAGEMENT, LLC | 274,782 | $1,151,000 | 0.04% |
| QS BATTERYMARCH FINANCIAL MANAGEMENT, INC | 338,703 | $1,420,000 | 0.04% |
| WELLINGTON MANAGEMENT GROUP LLP | 29,627,959 | $124,141,000 | 0.03% |
| Cambridge Investment Research Advisors, Inc. | 268,118 | $1,123,000 | 0.03% |
| OppenheimerFunds, Inc. | 7,000,000 | $29,330,000 | 0.03% |